Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2^+ glioma patients

スポンサーリンク

概要

論文の詳細を見る
2008-08-10

著者

ITOH Kyogo
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
YAMADA Akira
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
Yamada Akira
久留米大学医学部泌尿器科
Yamada A
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
Yamada Akira
Kurume University Research Center For Innovative Cancer Therapy Kurume University School Of Medicine
Itoh K
Kurume Univ. School Of Medicine Fukuoka
Itoh Kyogo
久留米大学医学部免疫学
NIKAWA JUNICHI
Department of Biochemical Engineering and Science, Kyushu Institute of Technology
Itoh K
Kurume Univ. School Of Medicine Fukuoka Jpn
Yao Akihisa
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy And Center Of The
Nikawa Junichi
Department Of Biochemical Engineering And Science Kyushu Institute Of Technology
Nikawa Junichi
Department Of Bioscience And Bioinformatics Kyushu Institute Of Technology
SHICHIJO Shigeki
Department of Immunology, Kurume University School of Medicine
Itoh K
Department Of Immunology Kurume University School Of Medicine
Itoh K
Departments Of Immunology Kurume University School Of Medicine
Itoh Kyogo
Departments Of Immunology ; Departments Of Cancer Vaccine Division Of Kurume University Research Cen
Itoh Kyogo
Division Of Cancer Vaccine Development At The Research Center For Innovative Cancer Therapy Kurume U
Itoh Kyogo
Department Of Lmmunology Kurume University School Of Medicine
KOMOHARA Yoshihiro
Cancer Vaccine Development Division, Research Center for Innovative Cancer Therapy, Kurume Universit
Shichijo S
Department Of Immunology Kurume University School Of Medicine
Shichijo Shigeki
Departments Of Immunology
Itoh Kyogo
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
Itoh Kyogo
Cancer Vaccine Development Division Research Center For Innovative Cancer Therapy Kurume University
Komohara Yoshihiro
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
Yamada Akira
Department Of Immunology Kurume University School Of Medicine
JIN Mingyue
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
YAMANAKA Ryuya
Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy
Jin Mingyue
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
Yamanaka Ryuya
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy
Shichijo Shigeki
Department Of Immunology And Immunotherapy Kurume University School Of Medicine
Kakehi Yoshiyuki
Department Of Urology Kagawa University Graduate School Of Medicine
Yamada Akira
Cancer Vaccine Development Division Kurume University Research Center For Innovative Cancer Therapy

関連論文

もっと見る

スポンサーリンク